THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
Press Releases
- NIH Human Microbiome Project defines normal bacterial makeup of the body
- Advaxis ADXS-PSA Construct Causes Significant Tumor Regression in Preclinical Prostate Cancer Study
- Filtrona Porous Technologies Acquisition of Lymtech Scientific Expands Technology Into Porous Speciality Wiping Materials
- Clinical Trial of Human Hookworm Vaccine Begins at Children's National Medical Center
- Cocaine vaccine gets a boost with molecular imaging
- More Press Releases
Featured Jobs
-
Program Lead - Scientific Information Architecture & Search
Merck - Kenilworth, NJ -
Associate Scientist I - SAP-QM Consultant Job
Yoh - Vacaville, CA, USA -
Pharmacovigilance Scientist Job
Yoh - South San Francisco, CA, USA -
Forecasting/Analytics Manager
Sucampo Pharmaceuticals - Washington, DC -
Director, Lymphoma Marketing Job
Celgene Corporation - Summit, NJ, US
Latest Commentary